With a focus on delivering improved patient services and outcomes, this year’s Life Sciences Forum promises to pack a punch, giving delegates access to a series of high-profile speakers and sessions exploring some of the challenges, new and old, facing industry when working with the NHS.
Government initiatives in recent years have identified that patient access to new treatments and technologies is imperative if outcomes are to improve. There has been little progress so far because the NHS is facing a huge financial challenge while simultaneously attempting to transform services through the STP process and formation of ICSs.
The HSJ Life Sciences Forum is an exclusive event for representatives from industry who seek to develop relationships with and deliver innovation to the NHS.
Our Keynote will be delivered by Baroness Blackwood, Parliamentary Under Secretary of State for Health, Department of Health and Social Care. Baroness Blackwood will be discussing the next steps for industry and the NHS on the implementation of the Life Sciences Industrial Strategy.
Hear from: Dr Sam Roberts, Director of Innovation, Research and Life Sciences Group, NHS England in our Panel Discussion: What the NHS 10-year plan means for industry.
Professor Dame Sue Hill, Chief Scientific Officer, NHS England will be talking about how we can unleash the potential of genomics and personalised medicine alongside Joanne Hackett, Chief Commercial Officer, Genomics England
Other speakers include:
- Mike Thompson, Chief Executive, ABPI
- James Roach, Director, West Essex ICP
- Dr Phil Richardson, Chief System Integration Officer, Dorset ICS
- Meindert Boysen, Centre for Health Technology Evaluation Director, NICE
- Dr Ian Hudson, Chief Executive, MHRA
- Sue Bailey, Strategic Partnership and Early Asset Director, BMS
- Blake Dark, NHS Commercial Medicines Director, NHS England
- Steve Oldfield, Chief Commercial Officer, Department of Health and Social Care
- Louise Houson, Managing Director UK, MSD
- Sir John Bell, Regius Professor of Medicine, University of Oxford
- Tamsin Berry, Deputy Director, Office for Life Sciences
- Tunde Falude, Managing Director, Sanofi
- Nicole Mather, Non-Executive Director, Health Research Authority
Review the full programme here